Search Results
Department of Pathology, General University Hospital of Ciudad Real, Ciudad Real, Spain
Search for other papers by Ana Isabel Álvarez-Mancha in
Google Scholar
PubMed
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Málaga, Spain
Search for other papers by Isabel Mancha-Doblas in
Google Scholar
PubMed
The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA-BIONAND Platform), University of Malaga, Malaga, Spain
Search for other papers by María Molina-Vega in
Google Scholar
PubMed
Search for other papers by Diego Fernández-García in
Google Scholar
PubMed
The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA-BIONAND Platform), University of Malaga, Malaga, Spain
Search for other papers by Ana María Gómez-Pérez in
Google Scholar
PubMed
Department of Pathology, Virgen de la Victoria University Hospital, Málaga, Spain
Search for other papers by Elena Gallego-Domínguez in
Google Scholar
PubMed
Department of Pathology, Virgen de la Victoria University Hospital, Málaga, Spain
Search for other papers by María Victoria Ortega-Jiménez in
Google Scholar
PubMed
Search for other papers by Isabel Hierro-Martín in
Google Scholar
PubMed
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Málaga, Spain
The Biomedical Research Institute of Malaga and Platform in Nanomedicine (IBIMA-BIONAND Platform), University of Malaga, Malaga, Spain
Search for other papers by Francisco J Tinahones in
Google Scholar
PubMed
Introduction Clinical management of the thyroid nodules is based on a combination of clinical risk factors, functional status, ultrasound patterns, and cytologic findings when fine needle aspiration (FNA) is indicated ( 1 , 2 , 3 , 4 , 5
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Nunzia Tacelli in
Google Scholar
PubMed
Search for other papers by Lucia Russo in
Google Scholar
PubMed
Search for other papers by Laetitia Lebrun in
Google Scholar
PubMed
Search for other papers by Isabelle Salmon in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
-TIRADS) classification and to evaluate their cytological and molecular aspect. Materials and Methods Patients and study design This is a single-centre, observational, prospective study performed between March 2018 and September 2021, on 901 patients aged ≥18
Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedűs in
Google Scholar
PubMed
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
Search for other papers by Andrea Frasoldati in
Google Scholar
PubMed
Search for other papers by Laszlo Jambor in
Google Scholar
PubMed
Search for other papers by Zsolt Karanyi in
Google Scholar
PubMed
Search for other papers by Gabor L Kovacs in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Karoly Rucz in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
Introduction For more than three decades, the cornerstones in the clinical management of patients with thyroid nodules have been ultrasound (US) and fine-needle aspiration cytology (FNA) ( 1 , 2 , 3 ). Robust evidence demonstrates that the
Search for other papers by M Grussendorf in
Google Scholar
PubMed
Search for other papers by I Ruschenburg in
Google Scholar
PubMed
Search for other papers by G Brabant in
Google Scholar
PubMed
ultrasound (US) criteria and possibly fine-needle aspiration cytology (FNAC), malignancy rates may be overestimated and will not necessarily reflect the chances of a nodule being first diagnosed by palpation or imaging methods. On the other hand, ROM may as
Medical School, University of Milan, Milan, Italy
Search for other papers by Stamatina Ioakim in
Google Scholar
PubMed
Division of Diabetes, Endocrinology & Gastroenterology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Search for other papers by Akheel A Syed in
Google Scholar
PubMed
Search for other papers by George Zavros in
Google Scholar
PubMed
Search for other papers by Michalis Picolos in
Google Scholar
PubMed
Department of Endocrinology and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Diabetes, Endocrinology & Obesity Medicine, Salford Royal NHS Foundation & University Teaching Trust, Salford, UK
Medical School, European University of Cyprus, Nicosia, Cyprus
Search for other papers by Angelos Kyriacou in
Google Scholar
PubMed
indicative of a benign nodule (U1–U2) should be regarded as reassuring not requiring fine-needle aspiration cytology (FNAC), unless the patient has a statistically high risk of malignancy’. AACE, American Association of Clinical Endocrinologists; ACE
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Maurilio Deandrea in
Google Scholar
PubMed
Search for other papers by Stefano Borgato in
Google Scholar
PubMed
Search for other papers by Marco Dell’Acqua in
Google Scholar
PubMed
Search for other papers by Francesca Retta in
Google Scholar
PubMed
Search for other papers by Alberto Mormile in
Google Scholar
PubMed
Search for other papers by Chiara Carzaniga in
Google Scholar
PubMed
Search for other papers by Giacomo Gazzano in
Google Scholar
PubMed
Search for other papers by Gabriele Pogliaghi in
Google Scholar
PubMed
Search for other papers by Marina Muzza in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
). According to the European Thyroid Association guidelines (ETA GLs) for image-guided ablation in benign thyroid nodules, one or two benign cytologic results are needed before the procedure, and the treatment is not recommended for nodules with high-risk US
Search for other papers by Maria Mavromati in
Google Scholar
PubMed
Search for other papers by Essia Saiji in
Google Scholar
PubMed
Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed
Search for other papers by Vincent Lenoir in
Google Scholar
PubMed
Search for other papers by Amanda Seipel in
Google Scholar
PubMed
Search for other papers by Paulina Kuczma in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Search for other papers by Minerva Becker in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Claudio De Vito in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
with surgery, active surveillance, or local treatment, depending on the size of the nodule ( 3 , 4 , 5 , 6 ). Given the high rate of thyroid nodules, most of which are benign, to reduce fine needle aspiration cytology (FNAC) and unnecessary surgery
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Pi-Ling Chiang in
Google Scholar
PubMed
Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Sheng-Dean Luo in
Google Scholar
PubMed
Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Yen-Hsiang Chang in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Chen-Kai Chou in
Google Scholar
PubMed
Departments of Surgery, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan
Search for other papers by Shun-Yu Chi in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Search for other papers by Yi-Fan Chen in
Google Scholar
PubMed
Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan
School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung City, Taiwan
Search for other papers by Wei-Che Lin in
Google Scholar
PubMed
practice, thyroid nodules are being discovered with increasing frequency. Thyroid fine needle aspiration cytology (FNAC) is the most accurate test for determining malignancy and is an integral part of current thyroid nodule evaluation procedures ( 2
Search for other papers by Alessia Cozzolino in
Google Scholar
PubMed
Search for other papers by Tiziana Filardi in
Google Scholar
PubMed
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
Search for other papers by Ilaria Simonelli in
Google Scholar
PubMed
Search for other papers by Giorgio Grani in
Google Scholar
PubMed
Search for other papers by Camilla Virili in
Google Scholar
PubMed
Search for other papers by Ilaria Stramazzo in
Google Scholar
PubMed
Search for other papers by Maria Giulia Santaguida in
Google Scholar
PubMed
Search for other papers by Pietro Locantore in
Google Scholar
PubMed
Search for other papers by Massimo Maurici in
Google Scholar
PubMed
Search for other papers by Daniele Gianfrilli in
Google Scholar
PubMed
Search for other papers by Andrea M Isidori in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Carlotta Pozza in
Google Scholar
PubMed
Search for other papers by on behalf of TALENT Group in
Google Scholar
PubMed
classification reporting US features in the transition age were selected. Inclusion criteria were (i) use of histology as a reference standard for the diagnosis of malignancy and histology or cytology as a reference standard for the diagnosis of benignity; (ii
Search for other papers by Rui Guo in
Google Scholar
PubMed
Search for other papers by Bowen Zheng in
Google Scholar
PubMed
Search for other papers by Tao Wu in
Google Scholar
PubMed
Search for other papers by Yufan Lian in
Google Scholar
PubMed
Search for other papers by Tinghui Yin in
Google Scholar
PubMed
Search for other papers by Yuting He in
Google Scholar
PubMed
Search for other papers by Jingya Qin in
Google Scholar
PubMed
Search for other papers by Zhicheng Yao in
Google Scholar
PubMed
Search for other papers by Wen Xu in
Google Scholar
PubMed
Search for other papers by Jie Ren in
Google Scholar
PubMed
-defined dominant nodules ( Fig. 1A , blue nodule), which were confirmed as Bethesda class II on cytology, with a largest diameter ≥20 mm and/or complaining of cosmetic or symptomatic problems; and (v) refusal or unable to undergo thyroidectomy due to underlying